Skip to main content
Visipaque 270 mg/mL injection, solution by GE Healthcare Inc.
Visipaque, 270 mg/mL, injection, solution Drug class: Radiographic Contrast Agent. Available on prescription only. Listed by GE Healthcare Inc..
Prescription only

Visipaque

Iodixanol

Listed by GE Healthcare Inc.

Strength
270 mg/mL
Form
Injection, Solution
Route
Intravascular
Class
Radiographic Contrast Agent

What it contains

  • Iodixanol 270 mg/mL

FDA record

Dosage form Injection, Solution
Route Intravascular
Drug class Radiographic Contrast Agent
Approval route NDA — original brand approval
NDC code 0407-2222
FDA application NDA020351
Package sizes listed 4
Marketed since December 2002

Other products containing Iodixanol

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Iodixanol

Strength
270 mg/mL
Form
Injection, Solution
Class
Radiographic Contrast Agent
Rx only Generic

FRESENIUS KABI USA, LLC

Not stocked by us — reference only

Iodixanol

Strength
320 mg/mL
Form
Injection, Solution
Class
Radiographic Contrast Agent
Rx only Generic

FRESENIUS KABI USA, LLC

Not stocked by us — reference only

Visipaque

Iodixanol

Strength
320 mg/mL
Form
Injection, Solution
Class
Radiographic Contrast Agent
Rx only

GE Healthcare Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.